Skip to main content
. 2021 Mar 10;65:103271. doi: 10.1016/j.ebiom.2021.103271

Fig. 3.

Fig 3

Establishment and evaluation of m6Ascore model in PDAC patients. (a) Kaplan-Meier survival analysis based on m6Ascore in ICGC-PDAC cohort (P = 0.0023, log-rank test); (b) Principal component analysis (PCA) of TCGA-PDAC patients based on the expression of the m6Ascore model; (c) Heatmap showed the expression profiles of nine m6A regulators that enrolled in the m6Ascore model in TCGA-PDAC patients. m6Ascore risk was listed as column annotations; Gradient m6Ascore was listed from left to right; (d) Expression of several key regulators of tumor metastasis were upregulated in m6Ascore-high patients than in m6Ascore-low patients; (e) COX regression and forest plot were applied to examine the hazard ratio (HR) and 95% confidence interval of each m6A regulators and the m6Ascore model.